Abstract
The new psychoactive substances (NPS) are a global and emerging phenomenon, with 111 countries having reported seizures and identification of more than 800 compounds, among which are synthetic cannabinoids, stimulants, hallucinogens and synthetic opioids. NPS have challenged the traditional approaches in monitoring, surveillance, control and public health protection measures in relation t…